Sign up for tax alert emails GTNU homepage Tax newsroom Email document Print document Download document | |||
January 28, 2021 Israeli Tax Authority releases final circular on payments to a parent company under cross-border recharge agreements for grant of stock-based compensation Executive summary The Israeli Tax Authority (ITA) has published the final circular (the Circular) regarding payments to a parent company under recharge agreements for the grant of stock-based compensation (SBC). This follows a draft circular (the Draft Circular) that was published by the ITA in March 2020.1 The purpose of this Circular is to outline the ITA’s position with respect to the intercompany payments between the Israeli company that employs the relevant employee to which the SBC is being granted and the parent company that issues the relevant SBC and its classification as reimbursement for participation of the parent company in payroll costs of the subsidiary versus dividend distribution. This Circular sets forth the ITA position where the expenses recorded for the grant of SBC were included as an expense/cost for purposes of Section 85A of the Income Tax Ordinance (ITO), in accordance with the Kontera Case.2 In order for an intercompany payment to be classified as a reimbursement for payroll expenses, the Circular requires the payment to be up to the payroll expense recorded in the financial statements for the grant of the SBC, to be final and not contingent on work, and agreed upon in advance. This Circular also aims to clear Reportable Position no. 70-2019, published in 2019, which created uncertainty with respect to such intercompany charges. This Circular corrects and clarifies this Reportable Position where the SBC expense is included for purposes of Section 85A of the ITO, according to the Kontera Case. Due to the significant impact of the Kontera Case, multinationals with operations in Israel should closely review this Circular and examine its potential impact on their recharge payments and overall SBC costs. Those with recharge payments and agreements not in accordance with the conditions of this Circular, as well as those not in compliance with the Kontera Case, should consider either aligning themselves with the ITA position or managing the risks involved, including the impact on tax provision. Since there is no transition provision, this Circular potentially also applies to past recharge payments. Detailed discussion The background of the Circular addresses the cases in which SBC is issued to an employee of an Israeli company (the Employing Company) for capital instruments of the (direct or indirect) parent company (the Granting Company), and the Granting Company charges the Employing Company for the payment of such capital instruments that were issued (the Intercompany Charge). The Circular mainly addresses service companies that are remunerated on a cost-plus basis, where the SBC costs are included in the cost base for calculating the cost-plus remuneration, as was ruled in the 2018 Supreme Court Kontera Case, but at the same time can apply to Israeli companies that serve as distributors on a Buy/Sell model. The Circular then determines under which circumstances the payment by the Employing Company to the Granting Company will be classified as a payroll expense reimbursement, and in which cases it will be considered a dividend distribution (or capital reduction, as relevant). It is clarified that the mere recharge payment should not be viewed as a deductible expense by the Employing Company, and such expense shall be recorded in accordance with the relevant GAAP, regardless of whether an Intercompany Charge exists, and will (or will not) be tax deductible in accordance with the Israeli Tax Ordinance. In order for a payment to the Granting Company to be considered as a participation in payroll expenses (rather than a dividend), it has to meet all the following conditions:
The Circular then stipulates that any payment that does not meet these conditions will be classified as a dividend (or capital reduction, as relevant), even if it was paid to a group company that is not the direct or indirect parent of the Employing Company. A reference that was made in the Draft Circular with respect to cases where the recharge payment is for the intrinsic value at the realization date, which provided that the payment up to the FMV of the instrument at the grant date (as recorded in the financial statements) will be considered as payroll expense reimbursement, where any additional amount will be considered as a dividend, was omitted in the final Circular that was published. A company that has a recharge agreement with the Granting Company and the payments thereunder meet all relevant conditions under this Circular, which are therefore classified as payroll expense reimbursement, is exempt from reporting reportable position no. 70-2019, which generally classifies such participation as a capital investment, and any following payment as a dividend (or capital reduction, as the case may be). The Circular also provides several examples to demonstrate the application of its provisions. Impact This Circular, together with the Kontera Case, will likely have a significant impact on multinationals operating research and development centers and other service companies in Israel. Those multinationals should closely review this Circular and consider its implications on their recharge payments and overall SBC costs. Those with recharge payments and agreements not aligned with the conditions of this Circular, as well as those non-compliant with the Kontera Case, that may face reclassifications of recharge payments into a dividend, should consider either aligning themselves with the ITA position or managing the risks involved, including the impact on their tax provision. Endnotes 1. See EY Global Tax Alert, Israeli Tax Authority releases draft circular for comments on payments to a parent company under recharge agreements for grant of stock-based compensation, dated 4 May 2020. 2. See EY Global Tax Alert, Israeli Supreme Court rules stock based compensation to be included in cost base for transfer pricing, dated 2 May 2018. 3. Also relevant for instruments that vest in tranches. _____________________________________________________________________________________________________________ For additional information with respect to this Alert, please contact the following: EY Israel, Tel Aviv
Ernst & Young LLP (United Sates), Israel Tax Desk, New York
ATTACHMENT | |||